ProjektPRIMAL-MDSC – Role of myeloid derived suppressor cells (MDSC) in intestinalinflammation and microbiome development

Grunddaten

Akronym:
PRIMAL-MDSC
Titel:
Role of myeloid derived suppressor cells (MDSC) in intestinalinflammation and microbiome development
Laufzeit:
01.12.2017 bis 30.11.2021
Abstract / Kurz- beschreibung:
The intestinal microbiome contributes to health maintenance. Pathological alterations in the
microbiome, the so called dysbiosis, may predispose to a variety of diseases. The main microbiome development starts directly after birth, with billions of bacteria encountering the newborns gut. To date it is mainly unknown how the neonatal immune system regulates this colonisation process and balance tolerance of symbiotic flora and protection from pathogens with an adequate inflammatory response. Myeloid derived suppressor cells are immature immune cells with anti-inflammatory activity. MDSC have been found in high numbers in the newborn. In this project the role of MDSC for control of intestinal inflammation during microbiome development will be analyzed. The results will help finding therapies contributing to a healthy development of the microbiome.
Schlüsselwörter:
Mikrobiom
microbiome
Neugeborene
newborn
dysbiosis

Beteiligte Mitarbeiter/innen

Leiter/innen

Medizinische Fakultät
Universität Tübingen
Medizinische Fakultät
Universität Tübingen

Lokale Einrichtungen

Medizinische Fakultät
Universität Tübingen

Geldgeber

Bonn, Nordrhein-Westfalen, Deutschland
Hilfe

wird permanent gelöscht. Dies kann nicht rückgängig gemacht werden.